Claritev (CTEV) Stock: Buy, Sell, or Hold?
CTEV - Claritev Corporation
$35.98
-0.76 (-2.07%)
âŧ
5d:
-7.96%
30d:
+1.87%
90d:
+12.33%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 07, 2026
0d
Get Alerted When CTEV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CTEV is fairly priced but lacks strong directional signals. At 8.2% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CTEV is fairly priced but lacks strong directional signals. At 8.2% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$55.67
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$34.57
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CTEV is currently trading at $35.98, which is considered fair relative to its 30-day fair value range of $32.85 to $39.86. From a valuation perspective, the stock is trading at a premium (Forward PE: 4.9) compared to its historical average (3.9). At these levels, the market is pricing in 8.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CTEV is in a uptrend. Immediate support is located at $33.87, while resistance sits at $42.00.
Market Sentiment: CTEV scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.83 (+27.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CTEV is in a uptrend. Immediate support is located at $33.87, while resistance sits at $42.00.
Market Sentiment: CTEV scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.83 (+27.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$32.85 -
$39.86
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.4% below Wall St target ($45.83)
- NEUTRAL: Trading at premium valuation - market expects 8.2% growth which is achievable
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$32.85 -
$39.86
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$33.87
Resistance Level
$42.00
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.91
Wall Street Target
$45.83
(+27.4%)
Revenue Growth (YoY)
6.6%
Profit Margin
-28.5%
Valuation Premium vs History
+8.2% premium
PE vs Historical
4.9 vs 3.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.2%
(market-implied from PE analysis)
1-Year Target
$38.93
(+8%)
2-Year Target
$42.12
(+17%)
3-Year Target
$45.58
(+27%)
3-Yr Target (if PE normalizes)
(PE: 5â4)
PE COMPRESSION
$36.21
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 26.2%)
$296.89
(+725%)
Base:
(SPY PE: 4.9, Growth: 26.2%)
$72.25
(+101%)
Bear:
(PE: 3.9, Growth: 26.2%)
$57.41
(+60%)
Share & Embed Analysis
Last updated: September 13, 2026 10:07 AM ET
Data refreshes hourly during market hours. Next update: 11:07 AM
Data refreshes hourly during market hours. Next update: 11:07 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTEV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 39 SELL |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 42 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 49 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
WAY
Waystar Holding Corp. CoâĻ |
STRONG BUY
13 analysts |
$33 | 45 HOLD |
